Cancer is a common enemy, and tumor detection is at the medical forefront. Every year, over 600,000 people lose their fight against cancer in the United States alone.
One of the many reasons why cancer is a fatal disease is the delay in diagnosis. Detecting the tumor early on, increases the odds of mitigation, remission, and possible cures. Guardant Health Inc.’s newly approved tumor detection test is a ray of hope in this regard.
Guardant Health Conducts Tumor Detection Testing
The U.S. Food & Drug Administration (FDA) recently approved Guardant360 CDx, the new testing method. Guardant Health introduced this technique that can detect cancerous tumors of any sort in patients. It is also an efficient method for detecting non-small lung cancer cells with an epidermal growth fac…